《大行報告》摩通料友邦(01299.HK)今年新業務價值可升30% 內地業務擴展可成催化劑
摩通發表研究報告指正就友邦(01299.HK)的2020年業績數字更新其財務預測,以及估算2023年的預期。公司將於5月公布首季營運數字,預期新業務價值錄16%增長,年保費收入增長為15%,新業務價值利潤率為57%。
該行指,雖然上述數字正面,但料市場對此反應不大,因公司於3月業績時,亦有透露首兩個月表現,故相信下一個催化劑將是內地業務擴張的消息。
該行下調今年新業務價值預測至36億美元,低於原先預測39億美元7%,因料亞洲各地的產品利潤率復甦緩慢,而東盟國家業務因疫情重新活躍而受影響。該行料全年新業務價值增長30%,年保費收入增長18%,新業務價值利潤率略改善至53%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.